BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

326 related articles for article (PubMed ID: 23771584)

  • 1. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M; van Doorn PA; Hughes RA
    Cochrane Database Syst Rev; 2013 Jun; (6):CD003280. PubMed ID: 23771584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M; Brassington R; Gunn AA; van Doorn PA; Hughes RA
    Cochrane Database Syst Rev; 2017 May; 5(5):CD003280. PubMed ID: 28481421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mahdi-Rogers M; Swan AV; van Doorn PA; Hughes RA
    Cochrane Database Syst Rev; 2010 Nov; (11):CD003280. PubMed ID: 21069674
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatments for chronic inflammatory demyelinating polyradiculoneuropathy (CIDP): an overview of systematic reviews.
    Oaklander AL; Lunn MP; Hughes RA; van Schaik IN; Frost C; Chalk CH
    Cochrane Database Syst Rev; 2017 Jan; 1(1):CD010369. PubMed ID: 28084646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2004 Oct; (4):CD003280. PubMed ID: 15495046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic drugs and interferons for chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA; Swan AV; van Doorn PA
    Cochrane Database Syst Rev; 2003; (1):CD003280. PubMed ID: 12535467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA; Mehndiratta MM
    Cochrane Database Syst Rev; 2012 Aug; (8):CD002062. PubMed ID: 22895925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA; Mehndiratta MM; Rajabally YA
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD002062. PubMed ID: 29185258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticosteroids for chronic inflammatory demyelinating polyradiculoneuropathy.
    Hughes RA; Mehndiratta MM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD002062. PubMed ID: 25561247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. WITHDRAWN: Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH; Hoogendijk JE; Lecky B; Winer JB; Gordon P
    Cochrane Database Syst Rev; 2009 Oct; (4):CD003643. PubMed ID: 19821312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis.
    Choy EH; Hoogendijk JE; Lecky B; Winer JB
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003643. PubMed ID: 16034905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
    Bus SR; de Haan RJ; Vermeulen M; van Schaik IN; Eftimov F
    Cochrane Database Syst Rev; 2024 Feb; 2(2):CD001797. PubMed ID: 38353301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mehndiratta MM; Hughes RA
    Cochrane Database Syst Rev; 2012 Sep; (9):CD003906. PubMed ID: 22972066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous immunoglobulin for chronic inflammatory demyelinating polyradiculoneuropathy.
    Eftimov F; Winer JB; Vermeulen M; de Haan R; van Schaik IN
    Cochrane Database Syst Rev; 2013 Dec; (12):CD001797. PubMed ID: 24379104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.
    Mehndiratta MM; Hughes RA; Pritchard J
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD003906. PubMed ID: 26305459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunomodulators and immunosuppressants for multiple sclerosis: a network meta-analysis.
    Filippini G; Del Giovane C; Vacchi L; D'Amico R; Di Pietrantonj C; Beecher D; Salanti G
    Cochrane Database Syst Rev; 2013 Jun; (6):CD008933. PubMed ID: 23744561
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with disease-modifying drugs for people with a first clinical attack suggestive of multiple sclerosis.
    Filippini G; Del Giovane C; Clerico M; Beiki O; Mattoscio M; Piazza F; Fredrikson S; Tramacere I; Scalfari A; Salanti G
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD012200. PubMed ID: 28440858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunosuppressive treatment in refractory chronic inflammatory demyelinating polyradiculoneuropathy. A nationwide retrospective analysis.
    Cocito D; Grimaldi S; Paolasso I; Falcone Y; Antonini G; Benedetti L; Briani C; Fazio R; Jann S; Matà S; Sabatelli M; Nobile-Orazio E;
    Eur J Neurol; 2011 Dec; 18(12):1417-21. PubMed ID: 21819489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy for IgM anti-myelin-associated glycoprotein paraprotein-associated peripheral neuropathies.
    Lunn MP; Nobile-Orazio E
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD002827. PubMed ID: 27701752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy.
    Umapathi T; Hughes RA; Nobile-Orazio E; Léger JM
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003217. PubMed ID: 16034892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.